can i take both glutathione and collagen You Together? Benefits Explained Daily vitamins but make it

Treatment for complete tears is timely surgical repair to optimize the chance of healing

Disclosure of interest: nothing to disclose Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.02 - ACUTE MANAGEMENT - Thrombolysis or thrombectomy P649 - ESOC25-2457 FUTILITY OF ENDOVASCULAR TREATMENT IN ISCHEMIC STROKE DUE TO TERMINAL INTERNAL CAROTID ARTERY OCCLUSION: A MULTICENTER STUDY Carmen Ramos 1 , Elena Lopez-Cancio 2 , Laura Llull Estrany 3 , Mar Castellanos 4 , Saima Bashir 5 , Fernando Ostos Moliz 6 , Antonio Cruz Culebras 7 , Pablo Iriarte Uribe-Echeverra 1 , Maria Castaon 2 , Antonio Doncel-Moriano 3 , Alexia Roel Garcia 4 , Mikel Terceo 5 , Patrica Calleja 6 , Natalia Mena Garca 7 , Alejandro Rodriguez 4 , Emma Caada 1 , Santiago Trillo Senin *1 1 Hospital Universitario de La Princesa, Madrid, Spain, 2 Hospital Universitario Central de Asturias, Oviedo, Spain, 3 Hospital Universitario Clinic de Barcelona, Barcelona, Spain, 4 Complejo hospitalario Universitario de A Corua, A Corua, Spain, 5 Hospital Universitario Josep Trueta, Girona, Spain, 6 Hospital Universitario 12 de Octubre, Madrid, Spain, 7 Hospital Universitario Ramn y Cajal, Madrid, Spain Background and Aims: Ischemic stroke due to terminal internal carotid artery occlusion (TICA) is a sever condition, with poor functional outcomes often occurring after endovascular treatment (EVT)

Profiles of antioxidant/electrophile response element (ARE/EpRE) nuclear protein binding and c-Ha-ras transactivation in vascular smooth muscle cells treated with oxidative metabolites of benzo[a]pyrene

Accordingly, phylogenetic analysis revealed close relationships with mecE and mecF of the known DCM degraders (Figure S3)

Manufactured by: HIKMA FARMACUTICA (PORTUGAL), S.A

Medulloblastoma in childhood: new biological advances